Baxter Heparin Production Increasing Following Wyeth Recall
Executive Summary
Baxter is increasing production of heparin sodium following a shortage of the anticoagulant
You may also be interested in...
Baxter Adding $200 Mil. In Critical Care Rx Sales Via ESI Lederle Deal
Baxter is adding about $200 mil. in annual sales to its anesthesia/critical care line via the acquisition of ESI Lederle from Wyeth
Baxter Adding $200 Mil. In Critical Care Rx Sales Via ESI Lederle Deal
Baxter is adding about $200 mil. in annual sales to its anesthesia/critical care line via the acquisition of ESI Lederle from Wyeth
AHP Exiting Oral Generics Business; K-Dur Settlement With FTC Near
American Home Products is phasing out its oral solid dosage form generic drug business, the company said in documents filed as part of the Federal Trade Commission suit against ESI Lederle